SHRINE Data Reference Guide

Contents Basics Terminology Availability and Maintenance Standards Core Standards Demographic Standards Diagnoses Standards Medications Standards Site to RxNorm Associations Type Mapping Site to NDR-RT Mapping Labs Standards Local Data Semantics Preservation Local Diagnoses Data BWH and MGH Diagnoses Local Medications Data BIDMC Medications BWH and MGH Medications CHB Medications [ SHRINE Help Main Menu ] | ### Site to RxNorm Associations Type Mapping For the ingredient name (IN) and trade name (BN), the BN is derived from FDA Trade Name, and is the same as IN in most cases. In cases where they differ, such as extended release variants with something similar to XL in the trade name, that component of the IN is not in the BN. A diagram indicates the datatype relationships for medication data. This relationship map is described as follows: IN → has_tradename → BN IN → ingedient_of → SCDC SCDC → has_tradename → SBDC IN → ingredient_of → SCDF SCDF → has_tradename → SBDF SCDF → inverse_isa → SCD SCD → has_tradename → SBD